135 results
6-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
7 Mar 24
Chemomab Therapeutics Announces Year End and Fourth Quarter 2023 Financial Results
7:00am
of Chemomab and its ability to successfully initiate and complete clinical trials and achieve regulatory milestones; the nature, strategy and focus
6-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
3 Jan 24
Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Primary
7:00am
trials and achieve regulatory milestones; the nature, strategy and focus of Chemomab; the development and commercial potential and potential benefits
6-K
EX-99.2
CMMB
Chemomab Therapeutics Ltd
9 Nov 23
Current report (foreign)
8:00am
to successfully initiate and complete clinical trials and achieve regulatory milestones; the nature, strategy and focus of Chemomab; the development
6-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
9 Nov 23
Current report (foreign)
8:00am
and reflect, in the opinion of management, all adjustments of a normal and recurring nature that are necessary for a fair statement of the Company’s financial
F-3/A
jlds22zb8z ngtbgs
30 Oct 23
Shelf registration (foreign) (amended)
8:33am
F-3
EX-4.1
jwijly
16 Oct 23
Shelf registration (foreign)
4:25pm
F-3
EX-1.2
kmmcko
16 Oct 23
Shelf registration (foreign)
4:25pm
F-3
wzj a6oxa4sjcv
16 Oct 23
Shelf registration (foreign)
4:25pm
6-K
EX-99.1
yzqxka
14 Aug 23
Current report (foreign)
8:05am
6-K
EX-99.3
c84wvt
14 Aug 23
Current report (foreign)
8:05am
8-K
EX-99.1
yimax8dajazdoiz00
5 Jun 23
Chemomab Therapeutics Announces Executive Leadership Changes and Provides a Corporate Update
7:00am
8-K
EX-99.1
v6l4cfawm01khmh mp2
11 May 23
Chemomab Therapeutics Announces First Quarter 2023 Financial Results and Provides a Corporate Update
6:10am
8-K
EX-99.1
h6x xyflqgwsm8g2
14 Nov 22
Chemomab Announces Appointment of Matthew Frankel, MD, MBA
4:06pm
8-K
EX-99.1
jj9a57w3pjwil jl
12 Aug 22
Chemomab Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update
7:08am
8-K
EX-99.1
eutg2c
21 Jun 22
Chemomab Therapeutics Appoints Jill M. Quigley, JD, to Its Board of Directors
7:00am